Characterization of a novel cell damage model induced by acid and pepsin using rat gastric epithelial cells: Protective effect of sucralfate

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 2, 1997, Pages 115-121

  Furukawa, O ^a   Nakamura, E ^a   Okabe, S ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Gastric epithelial cell damage; Pepsin; RGM1; Sucralfate

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2; PEPSIN A; SUCRALFATE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EPITHELIUM;

EID: 0031018872     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00394.x     Document Type: Article

References (24)

1. 2 on aspirin induced damage to rat gastric epithelial cells in tissue culture. Gut 1984; 25: 19 25.
2. Terano A, Ota S, Mach T. Prostaglandin protects against taurocholate-induced damage to rat gastric mucosal cell cultures. Gastroenterology 1987; 92: 669-77.
3. Romano M, Razandi M, Sekhon S, Krause WJ, Ivey KJ. Human cell line for study of damage to gastric epithelial cells in vitro. J. Lab. Clin. Med. 1988; 111: 430-40.
4. Romano M, Razandi M, Ivey KJ. Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture. Dig. Dis. Sci. 1990; 35: 467-76.
5. Nakamura K, Rokutan K, Marui N, Aoki A, Kawai K. Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 1991; 101: 161-6.
6. Zheng H, Shah PK, Audus KL. Primary culture of rat gastric epithelial cells as an in vitro model to evaluate antiulcer agents. Pharm. Res. 1994; 11: 77-82.
7. Hassan S, Konoshita Y, Min D. Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. Digestion 1996; 57: 196-200.
8. Kinoshita Y, Nakata H, Hassan S. Gene expression of keratinocyte and hepatocyte growth factors during the healing of rat gastric mucosal lesions, Gastroenterology 1995; 109: 1068-77.
9. Tsuji S, Sawaoka H, Kawano S. Effects of NS-398, a specific inhibitor for cyclooxygenase-2, on gastric cell proliferation. Gastroenterology 1995; 108: A245.
10. Nakamura E, Takahashi S, Okabe S. Effects of interleukin-1β on proliferation and mucus synthesis of rat gastric epithelial cells. Gastroenterology 1996; 110: A1103.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55-63.
12. Redo SF, Barnes WA, De La Sierra AO. Perfusion of the canine esophagus with secretion the upper gastrointestinal tract. Ann. Surg. 1959; 146: 555-6.
13. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969; 56: 223-30.
14. Lillemoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982; 92: 276-84.
15. Kaneko K, Guth PH, Kaunitz JD. In vivo measurement of rat gastric surface cell intracellular pH. Am. J. Physiol. 1991; 261: G548-52.
16. Samloff IM, O'Dell C. Inhibition of peptic activity by sucralfate. Am. J. Med. 1985; 799 (Suppl. 2C): 15-18.
17. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M, Takeuchi T. Pepstatin, a new pepsin inhibitor produced by actinomycetes. J. Antibiot. 1970; 23: 259-62.
18. Okabe S, Takeuchi K, Kunimi H, Kanno M, Kawashima M. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats. Dig. Dis. Sci. 1983; 28: 1034-42.
19. Harrington SJJ, Schegel JF, Code CF. The protective effect of sucralfate on the gastric mucosa of rats. J. Clin. Gastroenterol. 1981; 3 (Suppl. 2): 129-34.
20. Hollander D, Tarnawski A, Gergely H, Zipser RD. Sucralfate protection of the gastric mucosa against ethanol-induced injury: A prostaglandin mediated process? Scand. J. Gastroenterol 1984; 19 (Suppl. 101): 129-34.
21. Bighley LD, Giesing DH. Mechanism of action studies of sucralfate. In: Caspary WF (ed.) Duodenal Ulcer, Gastric Ulcer: Sucralfate. A New Therapeutic Concept. Urban & Schwarzenberg, Baltimore, 1981; 3-12.
22. Nagashima R. Mechanism of action of sucralfate. J. Clin. Gastroenterol. 1981; 3 (Suppl. 2): 117-27.
23. McGraw BF, Caldwell EG. Sucralfate. Drug Intell. Clin. Pharmacol. 1981; 15: 578-80.
24. Dranam DY, Sackman JW, Giesing DH, Runser DJ. In vitro absorption of bile salts and aspirin to sucralfate. Dig. Dis. Sci. 1984; 29: 402-6.